Enlivex Ltd. (ENLV) (CIK 0001596812) (ENLV)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Apr. 28, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 28, 2026 | CORRESP | Neutral/Informational | Moderate | Enlivex Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form F-3, which was filed on April 21, 2026. They are … | Read Filing EDGAR |
| Apr. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Enlivex Ltd. that it will not review the company's registration statement filed on April 21, 2026. The letter emphasizes the company's responsibility f… | Read Filing EDGAR |
| Dec. 30, 2025 | CORRESP | Neutral/Informational | Moderate | Enlivex Therapeutics Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form F-3, which was filed on December 23,… | Read Filing EDGAR |
| Dec. 29, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Enlivex Therapeutics Ltd. that it will not review their registration statement filed on December 23, 2025. The letter emphasizes that the responsibilit… | Read Filing EDGAR |